Time series prediction of plasma hormone concentration. Evidence for differences in predictability of parathyroid hormone secretion between osteoporotic patients and normal controls

K Prank, S J Nowlan, H M Harms, M Kloppstech, G Brabant, R D Hesch, T J Sejnowski, K Prank, S J Nowlan, H M Harms, M Kloppstech, G Brabant, R D Hesch, T J Sejnowski

Abstract

Recent evidence links osteoporosis, a disease of bone remodeling, to changes in the dynamics of parathyroid hormone secretion. We use nonlinear and linear time series prediction to characterize the secretory dynamics of parathyroid hormone in both healthy human subjects and patients with osteoporosis. Osteoporotic patients appear to lack the periods of high predictability found in normal humans. Our results may provide an explanation for why an intermittent administration of parathyroid hormone is effective in restoring bone mass in osteoporotic patients.

References

    1. Science. 1991 Nov 15;254(5034):1024-6
    1. Endocrinology. 1983 Mar;112(3):1000-6
    1. J Clin Endocrinol Metab. 1989 Oct;69(4):843-51
    1. J Biol Chem. 1984 Apr 10;259(7):4019-22
    1. Endocrinology. 1986 Oct;119(4):1654-9
    1. Recent Prog Horm Res. 1989;45:507-27; discussion 527-31
    1. Phys Rev A. 1990 Jan 15;41(2):1169-1171
    1. Calcif Tissue Int. 1989 Mar;44(3):176-80
    1. Nature. 1990 Apr 19;344(6268):734-41
    1. Ann N Y Acad Sci. 1987;504:16-32
    1. Am J Physiol. 1994 Apr;266(4 Pt 1):E653-8
    1. J Bone Miner Res. 1986 Aug;1(4):377-81
    1. J Clin Endocrinol Metab. 1978 Nov;47(5):1021-7
    1. Lab Invest. 1988 Oct;59(4):418-42
    1. J Bone Miner Res. 1991 Oct;6(10):1071-80
    1. Endocrinology. 1982 Feb;110(2):506-12
    1. J Clin Endocrinol Metab. 1978 Aug;47(2):284-9
    1. Biol Cybern. 1991;66(2):159-65
    1. N Engl J Med. 1988 Mar 31;318(13):818-28
    1. J Clin Endocrinol Metab. 1990 Jan;70(1):252-63
    1. Proc Natl Acad Sci U S A. 1981 May;78(5):3204-8
    1. Science. 1977 Jul 15;197(4300):287-9
    1. J Bone Miner Res. 1990 Dec;5(12):1193-200

Source: PubMed

3
订阅